Provention Bio Announces Initiation of Phase 2b PROACTIVE Study of PRV-015 (anti-IL-15) in Non-responsive Celiac Disease | Antibodies | News Channels – PipelineReview.com

Uncategorized

Provention Bio Announces Initiation of Phase 2b PROACTIVE Study of PRV-015 (anti-IL-15) in Non-responsive Celiac Disease | Antibodies | News Channels  PipelineReview.com
Provention Bio Announces Initiation of Phase 2b PROACTIVE Study of PRV-015 (anti-IL-15) in Non-responsive Celiac Disease | Antibodies | News Channels – PipelineReview.com
Source: Nigerian Healthcare Blog

Tagged

Review Overview

Summary

Leave a Reply